Nature Reviews Clinical Oncology

Vol. 22, Issue 7 Issue 7 2025
10
Articles

Articles in this Issue

Prospective comparisons support the use of navigational bronchoscopy

Peter Sidaway Jul 01, 2025 pp. 460-460 10.1038/s41571-025-01039-5

Benefit from huCAR19-IL18 cells in patients with CD19+ lymphomas after CAR T cells

Diana Romero Jul 01, 2025 pp. 460-460 10.1038/s41571-025-01036-8

Tumour and microenvironment crosstalk in NSCLC progression and response to therapy

Zahraa Rahal, Roy El Darzi, Seyed Javad Moghaddam et al. Jul 01, 2025 pp. 463-482 10.1038/s41571-025-01021-1

Targeting the glioblastoma resection margin with locoregional nanotechnologies

Thomas Kisby, Gerben R. Borst, David J. Coope et al. Jul 01, 2025 pp. 517-537 10.1038/s41571-025-01020-2

Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention

Ya-Qi Gao, Yong-Jie Tan, Jing-Yuan Fang Jul 01, 2025 pp. 499-516 10.1038/s41571-025-01026-w

Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer

Franz Rödel, Maximilian Fleischmann, Markus Diefenhardt et al. Jul 01, 2025 pp. 483-498 10.1038/s41571-025-01025-x

Promising results with zongertinib in advanced-stage HER2-mutant NSCLC

Diana Romero Jul 01, 2025 pp. 459-459 10.1038/s41571-025-01030-0

Next-generation KRAS-G12C inhibitor D3S-001 shows promise

David Killock Jul 01, 2025 pp. 459-459 10.1038/s41571-025-01028-8

The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab

Roy S. Herbst, Lieping Chen Jul 01, 2025 pp. 461-462 10.1038/s41571-025-01024-y

FDA approvals in 2024: new options for patients across cancer types and therapeutic classes

Sundeep Agrawal, Esther Park, Paul G. Kluetz Jul 01, 2025 pp. 457-458 10.1038/s41571-025-01018-w

All Issues

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page